BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18078566)

  • 1. Scheduling mammography screening for the early detection of breast cancer in Korean women.
    Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
    J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on scheduling periodic examinations for the early detection of breast cancer in Korea].
    Jeong SH; Kang DR; Hur NW; Kim J; Lee SY; Jung SH; Nam CM
    J Prev Med Public Health; 2006 Jul; 39(4):346-52. PubMed ID: 16910309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
    Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
    J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
    Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
    Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening and the increase in breast cancer incidence in Hawaii.
    Maskarinec G; Wilkens L; Meng L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):201-8. PubMed ID: 9138664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies.
    Cong XJ; Shen Y; Miller AB
    Stat Med; 2005 Oct; 24(20):3123-38. PubMed ID: 15977269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.
    Weedon-Fekjaer H; Lindqvist BH; Vatten LJ; Aalen OO; Tretli S
    J Med Screen; 2008; 15(2):83-90. PubMed ID: 18573776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J; Treasure P; Duffy S
    J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early breast cancer detection.
    Foti E; Mancuso S
    Minerva Ginecol; 2005 Jun; 57(3):269-92. PubMed ID: 16166936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings.
    Baker SG
    Biometrics; 1998 Dec; 54(4):1569-78. PubMed ID: 9883553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of mammography in different ethnic groups in Israel--analysis of mortality reduction and costs using CAN*TROL.
    Rennert G
    Cancer Detect Prev; 1991; 15(6):477-81. PubMed ID: 1723656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.